NSCLC STAGE IIIB

Clinical trials for NSCLC STAGE IIIB explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE IIIB trials appear

Sign up with your email to follow new studies for NSCLC STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1 Terminated 1

New combo offers hope for lung cancer patients resistant to targeted drugs

Disease control Completed

This study tested a combination of chemotherapy (platinum and pemetrexed) plus an immunotherapy drug (atezolizumab), with or without another drug (bevacizumab), in 150 adults with advanced non-squamous lung cancer that has specific gene changes (EGFR, ALK, or ROS1) and has stoppe…

Matched conditions: NSCLC STAGE IIIB

Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control

Last updated May 15, 2026 11:52 UTC

NSCLC STAGE IIIB

Get alerted when new NSCLC STAGE IIIB trials appear

New combo offers hope for lung cancer patients resistant to targeted drugs